vs

Side-by-side financial comparison of Digimarc CORP (DMRC) and IMMUCELL CORP (ICCC). Click either name above to swap in a different company.

Digimarc CORP is the larger business by last-quarter revenue ($8.9M vs $5.5M, roughly 1.6× IMMUCELL CORP). IMMUCELL CORP runs the higher net margin — -2.5% vs -47.2%, a 44.7% gap on every dollar of revenue. On growth, Digimarc CORP posted the faster year-over-year revenue change (2.9% vs -8.4%). Digimarc CORP produced more free cash flow last quarter ($895.0K vs $-1.8M). Over the past eight quarters, IMMUCELL CORP's revenue compounded faster (3.9% CAGR vs -5.3%).

Digimarc Corporation is a provider of enterprise software and services. The company's software, which includes digital identifiers, is designed to address counterfeiting, product authenticity, recycling accuracy, and supply chain traceability. Digimarc products are created for multiple industries such as apparel, consumer packaged goods, health and beauty, and automotive.

ImmuCell Corp is a US-based animal health biotechnology company that develops, manufactures and markets innovative products for livestock, primarily dairy cattle. Its core offerings include preventive and therapeutic solutions for common bovine health issues such as mastitis, serving agricultural producers and veterinary providers across North America.

DMRC vs ICCC — Head-to-Head

Bigger by revenue
DMRC
DMRC
1.6× larger
DMRC
$8.9M
$5.5M
ICCC
Growing faster (revenue YoY)
DMRC
DMRC
+11.3% gap
DMRC
2.9%
-8.4%
ICCC
Higher net margin
ICCC
ICCC
44.7% more per $
ICCC
-2.5%
-47.2%
DMRC
More free cash flow
DMRC
DMRC
$2.7M more FCF
DMRC
$895.0K
$-1.8M
ICCC
Faster 2-yr revenue CAGR
ICCC
ICCC
Annualised
ICCC
3.9%
-5.3%
DMRC

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
DMRC
DMRC
ICCC
ICCC
Revenue
$8.9M
$5.5M
Net Profit
$-4.2M
$-139.7K
Gross Margin
63.5%
42.9%
Operating Margin
-48.2%
0.4%
Net Margin
-47.2%
-2.5%
Revenue YoY
2.9%
-8.4%
Net Profit YoY
51.4%
80.1%
EPS (diluted)
$-0.18
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DMRC
DMRC
ICCC
ICCC
Q4 25
$8.9M
Q3 25
$7.6M
$5.5M
Q2 25
$8.0M
$6.4M
Q1 25
$9.4M
$8.1M
Q4 24
$8.7M
$7.8M
Q3 24
$9.4M
$6.0M
Q2 24
$10.4M
$5.5M
Q1 24
$9.9M
$7.3M
Net Profit
DMRC
DMRC
ICCC
ICCC
Q4 25
$-4.2M
Q3 25
$-8.2M
$-139.7K
Q2 25
$-8.2M
$501.9K
Q1 25
$-11.7M
$1.4M
Q4 24
$-8.6M
Q3 24
$-10.8M
$-701.7K
Q2 24
$-9.3M
$-1.5M
Q1 24
$-10.3M
$-437.9K
Gross Margin
DMRC
DMRC
ICCC
ICCC
Q4 25
63.5%
Q3 25
58.3%
42.9%
Q2 25
58.8%
43.7%
Q1 25
65.0%
41.6%
Q4 24
60.8%
36.5%
Q3 24
62.4%
26.3%
Q2 24
66.1%
22.5%
Q1 24
62.5%
31.6%
Operating Margin
DMRC
DMRC
ICCC
ICCC
Q4 25
-48.2%
Q3 25
-109.7%
0.4%
Q2 25
-105.2%
8.8%
Q1 25
-128.9%
13.9%
Q4 24
-105.1%
8.0%
Q3 24
-120.4%
-9.6%
Q2 24
-96.2%
-25.3%
Q1 24
-109.2%
-4.1%
Net Margin
DMRC
DMRC
ICCC
ICCC
Q4 25
-47.2%
Q3 25
-106.9%
-2.5%
Q2 25
-102.6%
7.8%
Q1 25
-125.2%
17.9%
Q4 24
-99.9%
Q3 24
-113.9%
-11.7%
Q2 24
-89.3%
-28.0%
Q1 24
-104.0%
-6.0%
EPS (diluted)
DMRC
DMRC
ICCC
ICCC
Q4 25
$-0.18
Q3 25
$-0.38
$-0.02
Q2 25
$-0.38
$0.06
Q1 25
$-0.55
$0.16
Q4 24
$-0.40
$0.09
Q3 24
$-0.50
$-0.09
Q2 24
$-0.43
$-0.20
Q1 24
$-0.50
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DMRC
DMRC
ICCC
ICCC
Cash + ST InvestmentsLiquidity on hand
$12.9M
$3.9M
Total DebtLower is stronger
$9.5M
Stockholders' EquityBook value
$40.2M
$29.8M
Total Assets
$53.0M
$45.7M
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DMRC
DMRC
ICCC
ICCC
Q4 25
$12.9M
Q3 25
$12.6M
$3.9M
Q2 25
$16.1M
Q1 25
$21.6M
Q4 24
$28.7M
$3.8M
Q3 24
$33.7M
Q2 24
$41.5M
$1.3M
Q1 24
$48.9M
$960.3K
Total Debt
DMRC
DMRC
ICCC
ICCC
Q4 25
Q3 25
$9.5M
Q2 25
Q1 25
$8.7M
Q4 24
$9.0M
Q3 24
$9.4M
Q2 24
$9.8M
Q1 24
$10.2M
Stockholders' Equity
DMRC
DMRC
ICCC
ICCC
Q4 25
$40.2M
Q3 25
$41.4M
$29.8M
Q2 25
$46.5M
$29.9M
Q1 25
$50.0M
$29.0M
Q4 24
$61.4M
$27.5M
Q3 24
$70.2M
$26.4M
Q2 24
$77.2M
$23.5M
Q1 24
$84.5M
$24.6M
Total Assets
DMRC
DMRC
ICCC
ICCC
Q4 25
$53.0M
Q3 25
$55.4M
$45.7M
Q2 25
$60.7M
$46.7M
Q1 25
$66.5M
$45.6M
Q4 24
$75.8M
$45.1M
Q3 24
$85.0M
$44.4M
Q2 24
$93.4M
$41.9M
Q1 24
$99.7M
$43.1M
Debt / Equity
DMRC
DMRC
ICCC
ICCC
Q4 25
Q3 25
0.32×
Q2 25
Q1 25
0.30×
Q4 24
0.33×
Q3 24
0.36×
Q2 24
0.42×
Q1 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DMRC
DMRC
ICCC
ICCC
Operating Cash FlowLast quarter
$991.0K
$-1.2M
Free Cash FlowOCF − Capex
$895.0K
$-1.8M
FCF MarginFCF / Revenue
10.0%
-32.3%
Capex IntensityCapex / Revenue
1.1%
10.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.3M
$715.4K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DMRC
DMRC
ICCC
ICCC
Q4 25
$991.0K
Q3 25
$-2.6M
$-1.2M
Q2 25
$-4.7M
$1.6M
Q1 25
$-5.5M
$1.6M
Q4 24
$-4.2M
$-3.1K
Q3 24
$-7.1M
$-639.3K
Q2 24
$-6.8M
$581.8K
Q1 24
$-8.4M
$418.5K
Free Cash Flow
DMRC
DMRC
ICCC
ICCC
Q4 25
$895.0K
Q3 25
$-2.8M
$-1.8M
Q2 25
$-4.9M
$1.4M
Q1 25
$-5.5M
$1.2M
Q4 24
$-4.2M
$-199.3K
Q3 24
$-7.2M
$-727.7K
Q2 24
$-6.9M
$471.0K
Q1 24
$-8.5M
$348.1K
FCF Margin
DMRC
DMRC
ICCC
ICCC
Q4 25
10.0%
Q3 25
-36.9%
-32.3%
Q2 25
-61.0%
22.4%
Q1 25
-59.1%
15.4%
Q4 24
-49.1%
-2.6%
Q3 24
-75.7%
-12.1%
Q2 24
-66.1%
8.6%
Q1 24
-85.8%
4.8%
Capex Intensity
DMRC
DMRC
ICCC
ICCC
Q4 25
1.1%
Q3 25
2.9%
10.8%
Q2 25
2.5%
2.4%
Q1 25
0.6%
4.1%
Q4 24
0.2%
2.5%
Q3 24
0.7%
1.5%
Q2 24
0.3%
2.0%
Q1 24
1.1%
1.0%
Cash Conversion
DMRC
DMRC
ICCC
ICCC
Q4 25
Q3 25
Q2 25
3.19×
Q1 25
1.09×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DMRC
DMRC

Subscription$5.3M60%
The Government$3.6M41%

ICCC
ICCC

Segment breakdown not available.

Related Comparisons